Search Results - "Si, Shuhui"
-
1
ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis
Published in Molecular therapy. Nucleic acids (05-03-2021)“…N6-methyladenosine (m6A) is the most commonly occurring internal RNA modification to be found in eukaryotic mRNA and serves an important role in various…”
Get full text
Journal Article -
2
Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability
Published in Journal of experimental & clinical cancer research (27-02-2018)“…Wilms' tumor 1-associating protein (WTAP) plays an important role in physiological processes and the development of tumor such as cell cycle regulation. The…”
Get full text
Journal Article -
3
Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis
Published in Cellular physiology and biochemistry (01-01-2018)“…Background/Aims: Chloroquine was formerly used as an anti-malarial agent drug but has now been proven to be useful for various diseases. This study aimed to…”
Get full text
Journal Article -
4
Microsphere amplified fluorescence and its application in sensing
Published in Biosensors & bioelectronics (15-12-2022)Get full text
Journal Article -
5
ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner
Published in Annals of translational medicine (01-05-2020)Get full text
Journal Article -
6
Disruption of tubular Flcn expression as a mouse model for renal tumor induction
Published in Kidney international (01-11-2015)“…The study of kidney cancer pathogenesis and its treatment has been limited by the scarcity of genetically defined animal models. The FLCN gene that codes for…”
Get more information
Journal Article -
7
Folliculin deficient renal cancer cells show higher radiosensitivity through autophagic cell death
Published in The Journal of urology (01-06-2014)“…Mutations in the FLCN gene are responsible for fibrofolliculoma, pulmonary and renal cysts, and renal cell carcinoma in patients with Birt-Hogg-Dubé syndrome…”
Get more information
Journal Article -
8
Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
Published in Oncotarget (20-10-2015)Get full text
Journal Article -
9
Optical Glass Microsphere Enabled Rapid Single‐Molecular Fluoroimmunoassay
Published in Advanced optical materials (01-07-2023)“…Determination of low‐abundance proteins in body liquid is the significant strategy for the early diagnosis of diseases and the discovery of signal paths in…”
Get full text
Journal Article -
10
MP16-11 HYPOXIA INDUCES RENAL CELL CARCINOMA PROLIFERATION BY HIF-DEPENDENT AND ALKBH5-MEDIATED M6A-DEMETHYLATION OF AURKB MRNA
Published in The Journal of urology (01-04-2019)Get full text
Journal Article -
11
Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells
Published in Journal of experimental & clinical cancer research (04-12-2013)“…Paclitaxel, a widely used chemotherapeutic drug, can induce apoptosis in variety of cancer cells. A previous study has shown preferential toxicity of…”
Get full text
Journal Article -
12
Methylenetetrahydrofolate reductase C677T polymorphism and colorectal cancer susceptibility: a meta-analysis
Published in Bioscience reports (22-12-2017)“…The association between methylenetetrahydrofolate reductase ( ) C677T polymorphism and colorectal cancer (CRC) susceptibility has been researched in numerous…”
Get full text
Journal Article -
13
Preoperative pelvic floor muscle exercise does not reduce the rate of postprostatectomy incontinence: evidence from a meta-analysis and a systematic review
Published in Translational andrology and urology (01-10-2020)“…A growing number of researches suggested that preoperative pelvic floor muscle exercise (PFME) was beneficial for urinary incontinence (UI) after a…”
Get full text
Journal Article -
14
Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients
Published in The pharmacogenomics journal (01-02-2019)“…The P450 oxidoreductase ( POR ) and peroxisome proliferator-activated receptor alpha ( PPARA ) genes are associated with the activity of cytochrome P450…”
Get full text
Journal Article -
15
MP39-09 RAPAMYCIN INHIBITS FLCN-DEFICIENT RENAL TUMOR GROWTH IN MICE
Published in The Journal of urology (01-04-2015)Get full text
Journal Article -
16
Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysis
Published in Oncotarget (22-08-2017)“…Previous studies have investigated the association between NAT2 polymorphism and the risk of prostate cancer (PCa). However, the findings from these studies…”
Get full text
Journal Article -
17
Polymorphisms of nucleotide factor of activated T cells cytoplasmic 2 and 4 and the risk of acute rejection following kidney transplantation
Published in World journal of urology (01-01-2018)“…Background Acute rejection (AR) is a common complication of kidney transplantation. Nuclear factors of activated T cells (NFATs) are transcription factors…”
Get full text
Journal Article -
18
Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A
Published in OncoTargets and therapy (2018)“…Long non-coding RNAs (lncRNAs) have emerged as key molecules in initiation and progression of prostate cancer (PCa). In this study, we aimed to explore the…”
Get full text
Journal Article -
19
Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting lnhibin-[beta] A
Published in OncoTargets and therapy (01-01-2018)“…Background/purpose: Long non-coding RNAs (lncRNAs) have emerged as key molecules in initiation and progression of prostate cancer (PCa). In this study, we…”
Get full text
Journal Article -
20
Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A [Corrigendum]
Published in OncoTargets and therapy (01-01-2019)Get full text
Journal Article